Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antidiabetic bicyclic compounds

Antidiabetic bicyclic compounds

US Patent 9957219 · Granted May 1, 2018

Estimated economic value: $129,774,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Factor XI activation inhibitors2025
Prevention and treatment of organ injuries2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Treatment and prevention of nephrotoxin-induced kidney injuries2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine r2025
PCSK9 antagonist compounds2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
PCSK9 antagonist compounds2024
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antag2024